Doping Journal Noteworthy Articles

Noteworthy section of the Doping Journal (ISSN 1812-948x) alerts interested readers about the selected noteworthy original research and viewpoint/review articles, book reviews, and meeting reports (published in other journals) on the subject of the Doping Journal scope.

DJ Home | Noteworthy home | DJ Content | Archiving your research in DJ is a new service by the Doping Journal DJ archive | Mission | PubMed | IFORA | Affiliates  | Contact us
We work for athletes, not corrupted antidoping officials, donate now to help us

October 29, 2007

Testosterone precursors: use and abuse in pediatric athletes

Write to authors to ask them to make this article freely available at DJ archive. Learn more

Pediatr Clin North Am. 2007 Aug;54(4):787-96, xii
Smurawa TM, Congeni JA
Northeastern Ohio Universities College of Medicine, 4209 State Route 44, PO Box 95, Rootstown, OH 44272, USA


The dietary supplements androstenedione, dehydroepiandrosterone, and androstenediol are precursors in the endogenous production of testosterone. The efficacy and safety of these prohormones are not well established but are promoted to have the same androgenic effects on building muscle mass and strength as anabolic-androgenic steroids. Studies have demonstrated repeatedly that acute and long-term administration of these oral testosterone precursors does not effectively increase serum testosterone levels and fails to produce any significant changes in lean body mass, muscle strength, or performance improvement compared with placebo. The Anabolic Steroid Control Act of 2004 lists androstenedione as a schedule III controlled substance, and it is regulated by the U.S. Food and Drug Administration. Testosterone precursors are banned by most major sports organizations.

PubMed ID, Record & Related articles

0 Comments:

Post a Comment

<< Home

DJ Home | Noteworthy home | DJ Content | Archiving your research in DJ is a new service by the Doping Journal DJ archive | Mission | PubMed | IFORA | Affiliates | Contact us